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Oby'ectives. The present study was performed to determine the
mechanisms for catecholamine-induced wall motion abnormalities
and to compare the diagnostic efficacy of two catecholamines :
arbutatnine and dobutamine .
Background. Catecholamine stress echocardiography is used to
induce regional wall motion abnormalities for the detection of
coronary artery disease, but the mechanism by which these
abnormalities occur is unknown.
Methods. Ten pigs were instrumented with left circumflex
coronary artery amerold constrictors, sonomicrometers to aneft-
sure transmural wall thickening in the left circumflex (ischemic)
and left anterior descending (control) coronary artery beds and a
pressure gauge to measure left ventricular pressure and its first
derivative (Pit). Myocardial blood flow was measured by
microspheres .
Results . At 38 ± 6 days (mean t SEM) after surgery, percent
wall thickening was normal at rest in both beds but abnormal in
the left circumflex coronary ar;,ary bed during atrial pacing . These
findings were associated with reduced myocardial blood flow in
the ischemic bed during atrial pacing. Dobutsndne infusion
Recurrent reversible ischemia without infarction character-
izes angina pectoris, a syndrome associated with coronary
artery disease . A principal effect of a bout of ischemia on
regional cardiac function is diminished systolic wall thicken-
ing. Echocardiography has been a useful adjunct to exercise
electrocardiography because regional myocardial function
can be observed with echocardiography, a distinct advan-
tage over other techniques . Because patients with coronary
artery disease often have concomitant peripheral vascular or
pulmonary disease, many of these patients are not able to
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increased percent wall thickening, with no differences between the
two beds (p = 0.63). In contrast, arbutamine laft ,ion increased
percent wall thickening only in the
flogschendc bed, with no effect
on percent wall thickening in the ischernic bed (p = 0 .03).
Although the endocardial/epicardial Mad flow ratio tended to
reduced in the left circumflex artery bed during catecholamine
infusion (p = 0 .07), both agents were similar in this effect . Despite
differences in function between the beds, there was no difference
in transmural myocardial blood flow between the two beds during
catecholamine infusion. When examined at matched metabolic
demands, arbutamine elicited greater differences in percent w
thickening than dobutandne between the two beds (p < 0.01) .
Conclusions . Arbutamine was able to provoke regional differ-
ences in function in a manner superior to dobutamine. This
occurred independently of altered transmural myocardial M
How or differences in hemodynamic effects between the agents.
Differences in their inotropic properties may be important in
explaining their different effects on ischemic arty rdiu
(I Am Coll Cardiol 1994,23.475-82)
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exercise. Therefore pharmacologic agents have been used to
provoke heterogeneities in coronary flow and abnormalities
in regional myocardial function, which can then be detected
either with thallium scintigraphy or echocardiography .
Echocardiographic assessment of wall motion during dobu-
tamine infusion has been used to diagnose coronary artery
disease (1) . This technique compares favorably with thallium
scintigraphy in determining the presence or absence of
coronary artery disease (1) . However, there are pharmaco-
logic features of dobutamine that might offset its ability to
provoke ischemia. For example, because it is a strong
positive inotrope, function might be expected, in some
circumstances, to be increased rather than decreased (2,3),
particularly if blood pressure and heart rate are not suffi-
ciently high. Indeed, some recent reports suggest that dob-
utamine may be relatively insensitive in detecting coronary
artery disease unless the extent of disease is severe (4-6) .
Arbutamine, a recently synthesized catecholamine drug, has
less inotropic but greater chronotropic actions than dobu-
tamine (7) . It is possible, therefore, that arbutamine may be
a more useful agent to provoke differences in regional
myocardial function and thereby be useful in the diagnosis of
coronary artery disease .
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A necessary limitation to the use of transthoracic echo-
cardiography in patients is the inability to obtain the spatial
resolution and precise quantitation of regional wall thicken-
ing that can be obtained in animals instrumented with
cardiac sonomicrometers placed directly on the heart . Fur-
thermore, animal models provide the ability to quantify
precisely regional myocardial blood flow
. In the current
study, we measured rcgional myocardial blood flow and
P!m.tion during debutamine and arbutamine infusion in
conscious anj!nals for the first time .
this investigation was conducted to compare the efficacy
of dobutamine and arbutamine in inducing differences in con-
tractile function between normally perfused and collateral-
depen4ent regions of the heart in a porcine model of myo-
cardial ischemia . We tested the hypothesis that arbutamine
would be superior to dobutamine in inducing contractile
abnormalities .
Methods
Anhoh. Ten sexually mature, 6-month old, 34 ± 5 kg
male Yucatan minipigs (Sus scrofo) were studied. All pigs
were obtained from the same vendor and were handled in a
similar manner. The protocol was in accordance with Na-
tional Institutes of Health guidelines for the use of animals in
research and was approved by the Animal Use Committee at
the University of California San Diego .
kawald nw6l We used a porcine model that mimics
coronary artery disease . Placement of an ameroid constric-
tor around the proximal left circumflex artery results in
gradual complete occlusion within 2 to 3 weeks with mifk;-
mal infarction (8-11). Myocardial function and blood flow
are normal at rest in the left circumflex artery bed because of
collateral vessel development, but flow reserve is insufficient
to prevent ischemia when myocardial oxygen demands in-
crease. Thus, the left circumflex artery bed is subjected to
episodic ischemia, analogous to clinical angina pectoris . An
advantage of the model is that each pig serves as its own
control, with a normally perfused and normally functioning
region (the left anterior descending coronary artery bed)
adjacent to a bed that, when metabolic demands are in-
creased, is inadequately perfused and abnormally function-
ing (left circumflex coronary artery bed) .
SuW7 aM Instrumentation. Pigs received ketamine
(50 mg&g body weight intramuscularly and atropine sulfate
(0.1 m&g intramuscularly followed by amytal sodium
(100 nwft intravenously . Pigs underwent endotracheal
intubation, and halothane (0 .5% to 1 .517b was delivered by a
ventilator for the duration of the surgical procedure . A left
thoracotomy was performed under sterile conditions for
instrumentation . Catheters were placed in the left atrium,
rta and pulmonary artery, providing a means to measure
regional blood flow by the microsphere technique (9-11 ,
monitor arterial blood pressure and infuse pharmacologic
agents. Wires were sutured on the left atrium to permit
electrocardiographic (ECG recording and atrial pacing .
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Ultrasonic micrometers measuring transmural thickness
were placed in the ischemic and nonischemic beds. Appro-
priate placement of the crystals was determined during
thoracotomy by occluding the artery (left circumflex or left
anterior descending coronary artery and confirming that
wall thickening decreased . A Konigsberg high fidelity pres-
sure manometer was placed in the left ventricular cavity
through an apical incision . Finally, an ameroid constrictor
was placed around the proximal left circumflex artery .
Details of the surgical procedure and instrumentation have
been described in detail elsewhere (8-11 .
Validation of the model . Studies were initiated 38 ± 6
days postoperatively . at a time when the ameroid had
completely closed, and collateral vessel growth and devel-
opment were stable (10,11 . Pigs were suspended in a sling,
and the ECG, left ventricular pressure, aortic pressure and
sonomicrometer signals from both beds were recorded in
digital format on-line at a sampling rate of 250/s per channel .
When pigs were relaxed (heart rate 96 ± 5 beats/min , atrial
pacing was begun . This was performed to establish that the
left circumflex coronary artery bed (ischemic showed a
relative decrease in systolic wall thickening at increased
heart rates and that the left anterior descending coronary
artery bed (normally perfused , by comparison, did not show
a relative decrease in systolic wall thickening . Pacing rates
were 150 and 180 beats/min . Radioactive microspheres were
injected at rest and during a paced heart rate of 180 beats/min
to assess myocardial blood flow to the two regions .
Pharmacologic studies . Dobutamine and arbutamine were
tested in random order in each animal . Pigs were suspended
in a sling for data acquisition . Left ventricular and aortic
pressures, sonomicrometer signals from both beds and the
ECG were recorded . When pigs were relaxed, control data
were collected (20 s . Incremental infusion of the pharmaco-
logic agent into the pulmonary artery then began. Infusion
time was 6 min/dose, with data collected the last 20 s of each
dose. Doses were 1 . 2, 4, 6, 12 .5, 25 and 50 pg/kg per min of
dobutamine and 5, 10, 20, 40, 80, 120, 360 and 200 nglg per
min of arbutamine . Microspheres were injected when a
maximal heart rate (approximately 150 beatsimin was
reached during infusion of each agent in each pig . Only one
drug a day was tested . Tests in individual pigs were com-
pleted within a 5-day interval .
Analysis of wall thickening. Data analyses were con-
ducted using the mean values obtained from 10 continuous
cardiac cycles of the acquired data . Data selection was made
on the basis of the integrity of the signal and absence of
motion artifact . Signals from the sonomicrometers were
amplified, calibrated and converted to distance (mm , as
previously described (9-11 . Calibration of the left ventric-
ular pressure transducer was accomplished by using the
indwelling left atrial catheter (low end and the indwelling
aortic catheter (high end . End-diastole was defined as the
point of initial positive first derivative of left ventricular
pressure (dP/dt , which was obtained by differentiating the
high fidelity left ventricular pressure waveform . End-systole
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was taken as the point 20 ms before peak negative dRIdi .
Percent wall thickening was calculated as :
ES WTh (mmlj
--
ED WTh [mm]
ED WTh [mm]
00 .
where ES = end-systolic, ED = end diastolic and WTh
wall thickness .
Determination of myocardial blood Hov . Myocardial
blood flow was determined by the radioactive microsphere
technique, as previously reported (9-11 . Transmural sam-
ples from the relevant beds were divided into inner (endo-
cardial , outer (epicardial and middle thirds, and blood flow
to each third and transmural flow were determined . Trans-
mural sections were taken in areas adjacent to the sonomi-
crometer crystals, thereby ensuring that blood flow measure-
ments would be from an area of myocardium that would
correlate with the functional measurements in each bed .
Necropsy . Pigs were anesthetized and killed at comple-
tion of the study . The left
circumflex
coronary artery % as
identified, and the ameroid constrictor was located and
examined to confirm complete closure .
Statistical analysis . Ten pigs were instrumented, and
heart rate was available in all 10 for both drugs . Blood
pressure responses were not available in I of the 10 pigs
during arbutamine infusion and in 2 of 10 pigs during
dobutamine infusion because of catheter occlusion . Because
of inadequate sonomicrometer signals, precise quantitation
of wall thickening was not available in 3 of 10 pigs for the
dobutamine tests and in 2 of 10 pigs for the arbutamine tests .
Endocardial blood flow during pacing (Fig. I was deter-
mined in a subset of five pigs only . Transmural blood flow
before and during catecholamine infusion was determined in
8 of 10 pigs (2 pigs had occluded left atrial catheters . Left
ventricular pressure signals were inadequate in 3 of 10 pigs,
requiring timing of the cardiac cycle to be based on endo-
cardial electrograms recorded from the sonomicrometers, a
method that we have previously validated (9 . Four of 10
pigs did not have adequate left ventricular pressure signals
and functioning micrometers in the left circumflex coronary
artery bed, so that examination of the dP/dt change at
matched rate-pressure products was limited to 6 pigs . A
prerequisite for direct comparisons between dobutamine and
arbutamine was that the crystal micrometers in both beds in
each pig were providing good signals, thereby permitting
direct comparisons. At the highest doses of arbutamine (160
to 200 ng/kg per min , the sonomicrometer and left ventric-
ular dP/dt waveforms were interpretable in only two animals .
These data were therefore not included in the analyses .
Comparisons of responses between the two beds during
catecholamine infusion were made using two-way repeated
measures analysis of variance . Post hoc analysis with regard
to differences in mean values between the two beds at a
specific dose were conducted with the use of Tukey analysis .
In other data sets, when single comparisons between the two
beds were made, Student s t test for paired data was used .
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Figure t . Top, At an atria (paced rate of 150 beats/min, wall
thickening in the left anterior descending coronary artery (LAD 6ed
was similar to basal conditions, but there was decreased wall
thickening in the left circumflex coronary artery (LCx
bed. At
higher heart rates, dysfunction was even more severe . Bottom,
Endocardial blood flow measured by radioactive microspheres
injected during atrial pacing (180 beats/min showed that coronary
blood flow was increased much less in the left circumflex than in the
left anterior descending coronary artery bed . Bars represent mean
value t SEM . Number above bar represents the p value (two-
tailed .
For comparisons at matched rate-pressure products, com-
parisons between unpaired data were used . The null hypoth-
esis (no difference between drugs was rejected when p <
0.05. Data are expressed as mean value ± SEM .
Results
Validation of the model. Figure I confirms that the model
represents myocardial ischemia . Specifically, systolic wall
thickening was impaired in the left circumflex coronary
artery (LCx bed in a mairner that was dependent on pacing
rate . By contrast, there was no significant change in systolic
wall thickening in the left anterior descending (LAD coro-
nary artery bed (nonischemic bed at these same rates .
Figure 1 also shows marked differences in the degree to
which endocardial blood flow increased during pacing at 180
beats/min (LAD : 95 ± 18% increase; LCx: 18
± 5% increase ;
p < 0 .0001 . Thus, side by side in each pig there is a normally
LCx BED
Before dobutamine
Before arbutamine
94 ± 5
97±6
*Basal conditions before infusion of either agent were not different . Values presented are mean value ± I SEM (n = 8 to 10 . HR = heart rate ; LAD = left
anterior descending coronary artery bed ; LAP = mean left atrial pressure ; LCx = left circumflex coronary artery bed ; MAP = mean arterial pressure ;
% WTh - % wall thickening .
perfused and normally functioning bed adjacent to an abnor-
mally perfused and abnormally functioning bed . It is impor-
tant to point out that in the basal state, both transmural
myocardial blood flow (LCx : 0.8 ± 0.2 ml/min/g ; LAD: 1 .0 ±
0.2 milmin per g, p = 0.08
and function (Table 1 were
similar in both beds . End-diastolic wall thickness in the left
circumflex coronary artery bed was similar at initial place-
ment of the crystals and at the end of the study (initial : 10.6
± 0.4 mm
; final
: 10.8 ± 0.9 mm
, confirming that no
significant wall thinning occurred during the course of the
study . In addition, previous studies from our laboratories
have documented, using quantitative microscopic analyses,
that there is minimal infarction (<5%
in the left circumflex
coronary artery bed (8, 10,11 .
Macy of eliciting differences in regional function . Heart
rates, loading conditions and percent wall thickening in both
beds were similar in the basal state before the infusion of
either agent (Table 1 . Pacing at 180 beats/min elicited similar
deficits in percent wall thickening in the left circumflex coro
.
LAD BED
LCX BED
DOBUTAMINE
BASAL
	
STIMULATED
I
13±3
11±2
115 8
110+4
BASAL
10.8 0.9
10 .7 1 .0
ARBUTANHNE
27±5
27 ± 5
STIMULATED
nary artery bed before infusion of either drug (before dobu-
tamine : -SO ± 7% ; before arbutamine : -55 ± 6%; p = 0.59 ,
documenting that the susceptibility to regional contractile
abnormalities was equivalent before infiision of either agent .
Finally, end-diastolic wall thickness and percent wag thicken-
ing were not different in the left circumflex or left anterior
descending coronary artery beds before infusion of either agent
(Table 1 .
Figures 2 and 3 show the effects of graded infusions of
dobutamine and arbutamine on wall thickening in the left
circumflex and left anterior descending coronary artery
beds. Dobutantine infusion resulted in increased wall thick-
ening in both the left circumflex and left anterior descending
coronary artery beds through a wide range of doses . The
responses of the two beds to dobutamine infusion were not
different (p = 0 .63
(Fig
. 3 . Therefore, in this model,
dobutamine appeared not to provoke regional dysfunction in
a bed that demonstrated dysfunction during pacing (Fig . 1 .
In contrast, arbutamine infusion resulted in increased wall
amm
6MM
7.8±0.5 38±6 3.2±0.5
7.9¢0.5 39±6 3.1±0.5
Figure 2. Actual data obtained from ul-
trasonic crystal micrometers placed
transmurally in the control (left anterior
descending coronary artery [LAD]
and
ischemic (left circumflex coronary ar-
tery [LCx]
regions from a representa-
tive pig before (basal
and during ca e
cholamine infusion (stimulated . Time is
shown along the X axis and distance
along the Y axis. Dashed vertical lines
represent end-diastolic and end-systolic
points
. These distances were used to
calculate percent wall thickening (see
Methods . The number associated with
each waveform represents the percent
wall thickening for the data shown .
Left, Dobutamine infusion (6 Agtkgtmin ;
heart rate 124 beats/min
sult d in
increased percent wall thickening in
both beds. Right, In contrast, arbu-
tamine infusion (40 ng/kg/min
; heart
rate 133 beats/min
resulted in incre s
percent wall thickening in the left ante-
rior descending coronary artery bed but
in decreased percent wall thickening in
the left circumflex coronary artery bed .
Quantitative summary data from both
regions for both agents over a wide
range of concentrations are shown in
Figure 3 .
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Conditions Before Infusion of Dobutamine and Arbutamine*
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HR LAP MAP LCx WTh LCx LAD WTh
LAD LCx Thickening
(beats/min (mm Hg (mm Hg (mm (% WTh (mm (% WTh (mm
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Figure 3. Top, Percent wall thickening increased in both the left
circumflex (LCx and left anterior descending (LAD coronary
artery beds through a wide range of concentrations of dobutamine
infusion . Percent wall thickening did not vary by region (analysis of
variance, p = 0 .63 . Bottom, Percent wall thickening increased in the
left anterior descending coronary artery bed but tended to decrease
in the left circumflex coronary artery bed in response to arbutamine
infusion. The pattern of change in percent wall thickening was
statistically different between the two regions overall (analysis of
variance, p = 0.03 . *p < 0 .01 . **p < 0.001 left circumflex coronary
artery versus left anterior descending coronary artery bed (Tukey
analysis . Points represent mean values . Error bars denote ± I SEM
(n = 7-8 .
thickening in the left anterior descending coronary artery
bed but either no change or decreased wall thickening in the
left circumflex artery bed (Fig . 2 and 3 . The responses of the
two beds *or; arbu!amine infusion were significantly different
(p = 0.03 through a range of doses that resulted in similar
increases in double (rate-pressure product (heart rate x
systolic blood pressure as dobutamine (see below . There-
fore, in this model arbutamine provoked regional dysfunc-
tion in a bed that demonstrated dysfunction during pacing
(Fig . 1 and provoked hyperfunction in the normally per-
fused bed. The maximal increase in wall thickening in the left
anterior descending coronary artery bed was somewhat
greater with dobutamine than with arbutamine (Fig . 3 , but
arbutamine infusion induced differences in regional function,
whereas dobutamine infusion did not .
Transmurall blood How during catecholamine infusion.
Figure 4 shows the effects of infusions of dobutamine and
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Figure 4. Top, Dobutamine versus arbutamine : effect on transmural
myocardial blood flow . At doses that yielded similar heart rates,
dobutamine (heart rate 154 ± 2 beats/min and arbutamine (heart
rate 155 ± 3 beats/min increased transmural myocardial blood flow
equally in both beds . Bottom, Dobutamine versus arbutamine : effect
on endocardial (ENDO /epicardial (EPI myocardial blood flow
ratios . At doses that yielded similar heart rates, arbutamine and
dobutamine affected endocardial/epicardial blood flow ratio between
the two beds similarly . Analysis of variance showed a tendency for
a reduced ratio in the left circumflex coronary artery (LCx bed (p =
0.07 , but the pattern of change in the ratio was similar for both
agents (p = 0.8 . Bars represent mean values . Error bars denote
I SEM. LAD = left anterior descending coronary artery .
arbutamine on blood flow to the left circumflex and left
anterior descending coronary artery beds . Microspheres
were injected during infused doses of the agents, which
resulted in similar heart rates (dobutamine 154 ± 2 beats/
min, arbutamine 155 ± 3 beats/min . Both agents increased
transmural blood flow roughly two times greater than basal
(unstimulated flow, and there was no evidence of decreased
transmural blood flow in the left circumflex coronary artery
bed, even though at these doses decreased systolic wall
thickening was observed with arbutamine (Fig . 3 . The
endocardial/epicardial blood flow ratio tended to decrease in
the left circumflex coronary artery bed during infusion of
either agent (p = 0.07 . This tendency was similar for both
agents (p = 0.8 (Fig. 4 . There was no alteration in trans-
mural, endocardial, midwall or epicardial blood flows be-
tween the two beds with either agent (Table 2 . There was no
difference in the relative myocardial blood flow ratios (LCx/
LAD between the two regions during infusion of the two
480 HAMMOND AND McKIRNAN
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Table 2 . Regional Myocardial Blood Flow During Dobutamine and Arbutamine Infusion at Matched Heart Rates*
*Analysis of variance found no differences in regional blood flow during infusion of either agent
. Transmural sections were divided into inner (endocardial ,
middle (midwall , and outer (epicardial
thirds
. Data presented are mean values (ml/min/g
± I SEM (n = 8
. LAD = left anterior descending coronary artery bed ;
LCx = left circumflex coronary artery bed .
agents: Transmural ratio - dobutamine : 1.0 ± 0.1 ; arbu-
tamine : 1 .0 ± 0.1 ; endocardial ratio - dobutamine : 0.9 ± 0
.1
;
arbutamine : 0.9 0.1; midwall ratio - dobutamine : 1 .6 ± 0.1 ;
arbutamine : 1 .1 0.1 ; epicardial ratio - dobutamine : 1
.0 ±
0.1 ; arbutamine : 1.1 ± 0.1 . To assess whether or not the
microspheres were distributed uniformly, samples were ob-
tained from the kidneys, and flow was found to be uniform in
the basal state (left kidney : 4 .3 ± 0.6 ml/glmin; right kidney :
4.4 0.5 ml/g/min , during dobutamine infusion (left kidney :
4.3 0.5 mi/g/min, right kidney : 4.8 ± 0 .8 ml/g/min
and
during arbutamine infusion (left kidney : 4.8 ± 0.6 ml/g/min,
right kidney : 5 .0 ± 0.5 ml/g/min .
Hernodynamic responses . Both agents had a dose-
dependent positive chronotropic effect . Because the doses
and potencies of the individual agents were different, it is not
logical to compare the drugs at each dose with respect to
their chronotropic capacities. The maximal change in heart
rate was not significantly different between the two agents
(dobutamine: 69 ± 9 beats/min ; drbutamine : 71 ± 12 beats/
min . No differences in arterial blood pressure responses
were observed between the two agents . The maximal de-
crease in diastolic blood pressure (dobutamine : -19 ±
13 mm Hg; arbutamine: -25 ± 4 mm Hg; p = NS
and the
maximal increase in systolic blood pressure (dobutamine :
8 ± 3 mm Hg
; arbutamine : 4 ± 7 mm Hg ; p = NS , were
similar . Baseline (before infusion
maximal left ventricular
dP/dt was not different before infusion of the two agents
(dobutamine : 2,064 ± 153 mm Hg/s ; arbutamine : 1,981 ±
96 mm Hg/s
; p = 0.70 . The maximal change in left ventric-
ular dP/dt was similar between the two agents (dobutamine :
2,060 ± 360 mm Hg/s ; arbutamine : 1,480 ± 480 mm Hg/s
;
p = 0
.35 .
DObutamift Versus arbulamine at matched rate-pressure
Product. The potencies of the agents tested are different, so
comparisons between dobutamine and arbutamine were
made by dividing data into tertiles of rate-pressure product
.
Figure 5 shows that arbutamine was associated with de-
creased, but dobutamine with increased function in the left
circumflex coronary artery bed through a wide range of
rate-pressure products . Figure 5 also shows that dobutamine
infusion was associated with greater increases in left ven-
tricular dP/dt than arbutamine at low and midrange rate-
pressure products. The maximal left ventricular dP/dt during
microsphere injection was greater during dobutamine than
during arbutamine infusion (dobutamine
: 3,706 ±
493 mm Hg/s
; arbutamine : 2,474 ± 205 mm Hg/s
; p = 0 .03
at rate-pressure products that were similar (dobutamine :
22,424 ± 1,408; arbutamine: 20,664 ± 1,497 ; p = 0.30 . Thus,
at matched metabolic demands and at similar transmural
myocardial blood flows to both beds (Fig. 4 , dobutamine
was a more potent inotrope than arbutamine .
Discussion
There are two key findings of this study . First, arbu-
tamine infusion results in different effects on ischemic and
Figure S. Top, At similar rate-pressure products (RPP
(heart rate
[HR] x systolic blood pressure (SBP] , arbutamine was associated
with mild dysfunction, but dobutamine was associated with in-
creased function in the ischemic bed . Bottom, At low and midrange
rate-pressure products, dobutamine increased the first derivative of
left ventricular pressure (dP/dt
to a greater extent than did arbu-
tamine. Bars represent mean values. Error bars denote ± 1 SEM .
Numbers above bars represent p values (two tailed . LCx WTh
left circumflex coronary artery bed wall thickening.
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Transmural Endocardial Midwall Epicardial
LCx LAD LCx LAD LCx LAD LCx LAD
Dobutamine 1 .9 ± 0.2 1 .9 ± 0.2 1 .5 ± 0.2 1 .7 ± 0 .1 2.1±0.2 2.1±0.2 2.0±0.2 It ± 12
Arbutamine 1 .7 ± 0.2 1 .7 ± 0.2 1 .3 ± 0.1 1 .5 ± Al 1.8±0
.2 1 .8±0.2 I.9±0.2 1.8±0 .3
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nonischemic regions in an animal model of myocardial
ischemia . In the normally perfused bed, wall thickening is
increased in a dose-dependent manner. In this respect arb-
utamine is not different from dohutamine . However, in the
collateral-dependent region, a region tl,at shows deficits in
flow and function during atrial pacing, regional wall thicken-
ing is decreased somewhat by arbutamine infusion. In con-
trast, dobutamine infusion increases function in the collateral-
dependent bed in a way that is quantitatively similar to the
left anterior descending coronary artery bed, a bed that
shows normal flow and function during pacing . The key
difference between the agents, therefore, is that dobutamine
increases function in the left circumflex coronary artery bed,
and arhutamine does not . Largely as a result of this differ-
ence, when comparing the two beds, there is a difference in
function in the two regions when arbutamine is infused but
not when dobutamine is infused (Fig . 2 and 3 . These data
indicate that arbutamine may be a useful agent for provoking
abnormalities in regional myocardial function when infused
in patients with coronary artery disease .
A second finding is that arbutamine affects regional
function differently in the two beds despite similar transmu-
ral blood flow to the two regions (Fig . 4, Table 2 . There was
a tendency for a reduced endocardial/epicardial blood flow
ratio in the left circumflex coronary artery bed . This effect
was similar for both drugs . Arbutamine and dobutaminc,
even in high doses, were not able to raise heart rate much
higher than 150 beats/min, the rate at which blood flow data
were obtained by injecting microspheres . It is possible that a
difference in blood flow may have become apparent if higher
heart rates had been achieved . However, despite no deficit
in transmural blood flow, there were distinct differences in
function elicited in the two beds with arbutamine but not
with dobutamine . Different effects on function, therefore,
must reflect different responsiveness of the beds to stimula-
tion by arbutamine . Therefore, we are left to explain why
arbutamine (but not dobutamine , in a manner independent
of transmural myocardial blood flow, was able to induce
differences in function between the two beds .
Dobutamine versus arbutamine . The different effects on
function in the left circumflex coronary artery bed might be
explained if the metabolic cost of contraction was higher
with arbutamine than with dobutamine . However, we have
shown that the maximal effects of these two agents on
hemodynamic responses were similar . Analyses were per-
formed to assess the ability of dobutamine and arbutamine to
provoke differences in function at matched rate-pressure
products (Fig . 5 . The results suggest that even with similar
metabolic demands, the effects of the two agents on regional
function in the left circumflex coronary artery bed were
different. Through a wide range of rate-pressure products,
dobutamine infusion resulted in increased function and arb-
utamine infusion resulted in small decreases in function in
the left circumflex coronary artery bed .
Perhaps dobutamine was a greater inotropic stimulus,
thus providing improved function, offsetting the increase in
metabolic demand. That is, if dobutamine was a more
effective inotrope, then one might expect regional dysfunc-
tion to be more difficult to elicit . When examined at matched
rate-pressure products, we found that at low and midrange
metabolic demands, dobutamine stimulated greater changes
in maximal left ventricular dP/dt than did arbutamine (Fig .
5 . There was no difference in change in maximal left
ventricular dP/dt between the two agents at the higher range
rate-pressure products . However, during microsphere injec-
tion, at a matched rate-pressure product, and with similar
transmural blood flows to both beds, maximal left ventricu-
lar dP/dt was greater with dobutamine than with arbutamine .
These data suggest that differences in the inotropic proper-
ties of the two agents may be of mechanistic importance in
their different effects on the two regions .
Because dobutamine and arbutamine both activate myo-
cardial -adrenergic receptors, an additional consideration
is that these two agents nia , interact with myocardial
f3-adrenergic receptors (or postreceptor elements differ-
ently . Possible differences in P-adrenergic receptor subtype
selectivity, for example, may offer a potential explanation
for different effects between the two beds . We have no data
to support or refute this speculation .
Previous studies. A recent study using acute critical ste-
nosis of the left circumflex coronary artery in anesthetized,
open chest dogs examined myocardial blood flow and re-
gional function during low dose (10 jag/kg per min dobu-
tamine infusion (12 . That study, like ours, found that
dobutamine infusion increased myocardial blood flow simi-
larly in both beds . In contrast to our study, however, they
found regional dysfunction in the left circumflex coronary
artery bed during dobutamine infusion . Conflicting results
may reflect the substantial differences in the models used .
For example, the well developed collateralization of the bed
at risk in our model (10,11 may have offset ischemic
dysfunction during dobutamine infusion . Other differences
in design between the two studies make comparisons didfli-
cult . The investigators studied anesthetized dogs using echo-
cardiography and a single dose of dobutamine, whereas we
studied conscious pigs using sonomicrometry and multiple
doses of dobutamine .
Schulz et al . (3 , using a low coronary flow model of
ischemia, found that intracoronary infusion of dobutamine
caused an enhancement of maximal work in the ischemic
myocardium despite decreased subendocardial flow . Their
study confirms the idea that, under some circumstances,
dobutamine can increase function in an ischemic bed
. In a
clinical study of patients with known coronary artery dis-
ease, Movahed et al . (13
showed with radionuclide imaging
that dobutamine infusion normalized previously existing
wall motion abnormalities in >80% of patients studied
.
Others (14
have reported improved regional myocardial
function during dobutamine infusion, so our findings cer-
tainly do not stand in isolation on this point .
Clinical implications . Recent clinical data (1
suggest that
dobutamine infusion during echocardiographic assessment
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of regional myocardial function is a useful method to diag- nary artery disease when used in conjunction
nose coronary artery disease . Data from the present study merit of regional myocardial function .
seem to contradict such studies. However, clinical studies
do not provide qvantltative assessment of regional wall
thickening, depending instead on qualitative differences in
wall motion . In such studies it may be that dysfunction is not
recognized to the same extent as hyperfunction . In other
words, it is possible that clinical studies with dobutamine are
really recognizing hyperfunction in normal regions and lack
of hyperfunction in regions susceptible to ischemia . It is also
interesting that clinical studies use high doses of dobutamine
(30 to 50 pg/Wmin . Lower doses are inadequate to provoke
qualitative differences in regional function (1 . In the present
study, maximal heart rates and rate-pressure products were
achieved at dobutamine infusion rates of 25 pgft per min. It
is possible that dobutamine may have provoked differences
in regional function had peak heart rates been raised higher
by the administration of atropine, for example (I . A poten-
tial limitation to the current study is that the model used is
analogous to single-vessel occlusion with collateral develop-
ment, anatomic features present in a minority of patients
undergoing catecholamine stress echocardiography . Con-
versely, data from the present study suggest that arbutamine
may provide accurate detection of coronary artery disease
even when the extent of disease is limited . Furthermore,
because arbutamine infusion resulted in significant differ-
ences in function between the two beds at lower rate-
pressure products (Fig . 3 and 5 , arbutamine may be a
miatively more sensitive agent than dobutamine for the
diagnosis of coronary artery disease .
ConchWoois. In the porcine ameroid model, arbutamine
provokes regional differences in function in a manner supe-
rior to dobutamine. The precise mechanism by which this
occurs is unclear, but it does not depend on altered trans-
mural myocardial blood flow or differences in hemodynamic
effects between dobutamine and arbutamine . Differences in
the inotropic properties of these two agents may be impor-
tant in their different effects on ischemic myocardium. The
results of this study suggest that arbutamine might be more
sensitive than dobutamine in the clinical diagnosis of coro-
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